[PDF][PDF] ADVANCES IN DRUG DEVELOPMENT

ST Ong - hematologyandoncology.net
STO The heterogeneity in responses that we observe among patients with CML was itself a
clue that there could be heritable variants. Normal variants in the human genome could …

[HTML][HTML] Heritable Resistance to Tyrosine Kinase Inhibitors

ST Ong - Clinical Advances in Hematology & Oncology …, 2014 - hematologyandoncology.net
STO I had been working with others in the field of drug resistance in chronic myeloid
leukemia (CML) for several years. One of the mysteries I had become interested in was why …